---
title: "Sonoma Pharmaceuticals special shareholder meeting lacked quorum, chairman canceled session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296403757.md"
description: "Sonoma Pharmaceuticals held an adjourned special shareholder meeting on August 19, 2026. The session was canceled due to a lack of quorum, resulting in no proposals being approved and no shareholder actions taken."
datetime: "2026-08-19T21:30:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296403757.md)
  - [en](https://longbridge.com/en/news/296403757.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296403757.md)
generator: "portal-rs"
---

# Sonoma Pharmaceuticals special shareholder meeting lacked quorum, chairman canceled session

-   Sonoma Pharmaceuticals held an adjourned special shareholder meeting on Aug. 19, 2026. \* No proposals were approved because the meeting was cancelled due to a lack of quorum. \* The company ended the meeting without taking any shareholder action. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sonoma Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-006608), on August 19, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [SNOA.US](https://longbridge.com/en/quote/SNOA.US.md)

## Related News & Research

- [Sonoma Pharmaceuticals Cancels Adjourned Special Stockholder Meeting](https://longbridge.com/en/news/296409897.md)
- [Sonoma Pharma ups at-the-market stock offering to $3.64 million](https://longbridge.com/en/news/290243754.md)
- [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2](https://longbridge.com/en/news/296129489.md)
- [CannaPharmaRx delays quarterly 10-Q filing for period ended June 30, 2026](https://longbridge.com/en/news/296135061.md)
- [Aardvark Therapeutics held annual shareholder meeting](https://longbridge.com/en/news/296141463.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**